Sacroiliac Joint Fusion Intervention For Mobility, Pain Relief, and Lasting Improvement in Functional Recovery "SIMPLIFY"
SIMPLIFY
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to determine the clinical efficacy of The Trellis SI Joint Fusion System in unilateral sacroiliac (SI) joint fusion surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedStudy Start
First participant enrolled
September 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2028
September 30, 2026
September 1, 2026
1 year
September 8, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fusion Evaluation through Computed Tomography (CT) Scan
Fusion evaluation through computed tomography (CT) scan at 18-month post operatively. Device placement will be confirmed by an Independent Radiologist using radiographic endpoints of the proportion of subjects who show at least 30% apposition of bone to both the iliac and sacral sides of at least 1 implant(s).
18 months
Bridging Bone
Bridging bone across the sacroiliac joint will be assessed as continuous bridging across the treated joint, occurring either adjacent to implants, distant from implants and/or adjacent/ distant from implants, degree of bridging (\<5% of joint, 5-15%, 15-30%, or 30-100%), signs of both positive and/ or adverse bone remodeling.
18 months
Interventions
TRELLIS SI Joint Fusion System
Eligibility Criteria
Primary care clinic
You may qualify if:
- Age ≥ 21 at time of screening;
- Diagnosis of unilateral sacroiliac (SI) joint dysfunction (degenerative sacroiliitis or sacroiliac disruption)
- Presence of low back/buttock pain and unresponsive to non-operative treatment for at least 6 months or has the presence of progressive symptoms in the face of conservative treatment; Oswestry Disability Index (ODI) score ≥ 30%;
- SIJ pain score ≥ 5 on 0-10 numerical rating scale (NRS);
- Ability and willingness to comply with follow-up regimen; and
- Written informed consent by the patient
You may not qualify if:
- Low back/buttock pain due to other causes including, but not limited to, lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degermation, or lumbar vertebral body fracture;
- Planned bilateral SI joint fixation
- Received prior SI joint fusion1;
- Cluneal neuralgia;
- Inflammatory sacroiliitis (e.g., ankylosing spondylitis, psoriatic arthritis, reactive arthritis, non-radiographical axial spondyloarthritis, inflammatory bowel disease-associated arthritis);
- Sacroiliac tumor as source of symptoms;
- Sacroiliac fracture or unresolved trauma as source of symptoms;
- Anatomic anomalies/defects that in the opinion of the Investigator preclude device placement
- History of recent (\<1 year) major trauma to pelvis;
- History of suspected history of severe osteoporosis (defined with a prior T-score \< -2.5 or history of osteoporotic fracture);
- Autoimmune disorders that impact the musculoskeletal system (e.g., lupus, rheumatoid arthritis);
- History of fibromyalgia;
- Infection at the site of surgery;
- Known or suspected allergies to titanium or titanium alloys
- Pregnant (verified in patients of childbearing potential by a negative urine pregnancy test when preadmission testing is obtained), or interested in becoming pregnant during the duration of the study;
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwest Specialty Hospital
Post Falls, Idaho, 83854, United States
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2026
First Posted
September 30, 2026
Study Start
September 30, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2028
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared